Novel ABCG2 antagonists to reverse topotecan-mediated chemotherapeutic resistance in ovarian carcinoma xenografts.
收藏NIAID Data Ecosystem2026-03-11 收录
下载链接：
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE85582
下载链接
链接失效反馈官方服务：
资源简介：
In order to address the treatment difficulties associated with chemotherapetic resistance in ovarian cancer, we combined our compounds with topotecan and admininstered the mixture to chemoresistant Igrov1/T8 ovarian cancer cells in vitro and Igrov1/T8 xenografts in CB-17 SCID mice. We ran 2 Parental Igrov1 ovarian cancer cells and 2 Igrov1 derived cell line overexpressing ABCG2, Igrov1/T8.
创建时间：
2019-03-15
